Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

DAHLIA S LANDA

Allopathic & Osteopathic Physicians Allergy & Immunology

NPI
1922276781
CMS profile
177994
Location
BRONX, NY

General Payments · PY2018–2024

$8,028.69

  • Reported across 332 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$1,155.22

57 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $1,097.40 56
Education $57.82 1

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
GENZYME CORPORATION $341.47 13
GlaxoSmithKline, LLC. $235.84 12
Acerta Pharma LLC $235.44 7
OptiNose US, Inc. $145.25 16
Regeneron Healthcare Solutions, Inc. $57.82 1
Grifols USA, LLC $47.06 3
Kaleo, Inc. $42.63 2
NOVARTIS PHARMACEUTICALS CORPORATION $32.29 2
Amgen Inc. $17.42 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $1,604.92 38
PY2019 $733.58 43
PY2020 $730.76 33
PY2021 $704.42 38
PY2022 $2,038.40 72
PY2023 $1,061.39 51
PY2024 $1,155.22 57

Payment records · PY2024 (57)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Amgen Inc. $17.42 01/10/2024 Food and Beverage Undisputed 01/23/2026 1111628010 CMS
AstraZeneca Pharmaceuticals LP $108.42 02/24/2024 Food and Beverage Undisputed 01/23/2026 1105724361 CMS
AstraZeneca Pharmaceuticals LP $23.00 05/23/2024 Food and Beverage Undisputed 01/23/2026 1104600722 CMS
AstraZeneca Pharmaceuticals LP $16.20 05/23/2024 Food and Beverage Undisputed 01/23/2026 1104705917 CMS
AstraZeneca Pharmaceuticals LP $16.98 08/06/2024 Food and Beverage Undisputed 01/23/2026 1104626202 CMS
AstraZeneca Pharmaceuticals LP $28.12 09/24/2024 Food and Beverage Undisputed 01/23/2026 1105775716 CMS
AstraZeneca Pharmaceuticals LP $17.14 10/15/2024 Food and Beverage Undisputed 01/23/2026 1104424121 CMS
AstraZeneca Pharmaceuticals LP $25.58 10/29/2024 Food and Beverage Undisputed 01/23/2026 1104605580 CMS
GENZYME CORPORATION $25.40 01/22/2024 Food and Beverage Undisputed 01/23/2026 1139730290 CMS
GENZYME CORPORATION $29.75 01/30/2024 Food and Beverage Undisputed 01/23/2026 1139730292 CMS
GENZYME CORPORATION $31.03 02/08/2024 Food and Beverage Undisputed 01/23/2026 1139730296 CMS
GENZYME CORPORATION $27.68 03/26/2024 Food and Beverage Undisputed 01/23/2026 1139730304 CMS
GENZYME CORPORATION $34.07 06/20/2024 Food and Beverage Undisputed 01/23/2026 1139730316 CMS
GENZYME CORPORATION $32.73 07/23/2024 Food and Beverage Undisputed 01/23/2026 1139730344 CMS
GENZYME CORPORATION $14.53 08/21/2024 Food and Beverage Undisputed 01/23/2026 1139730362 CMS
GENZYME CORPORATION $23.38 08/29/2024 Food and Beverage Undisputed 01/23/2026 1139730368 CMS
GENZYME CORPORATION $9.49 09/18/2024 Food and Beverage Undisputed 01/23/2026 1139730376 CMS
GENZYME CORPORATION $31.85 10/01/2024 Food and Beverage Undisputed 01/23/2026 1139730378 CMS
GENZYME CORPORATION $31.28 11/05/2024 Food and Beverage Undisputed 01/23/2026 1139730390 CMS
GENZYME CORPORATION $24.26 12/06/2024 Food and Beverage Undisputed 01/23/2026 1139730408 CMS
GENZYME CORPORATION $26.02 12/24/2024 Food and Beverage Undisputed 01/23/2026 1139730416 CMS
GlaxoSmithKline, LLC. $17.53 01/25/2024 Food and Beverage Undisputed 01/23/2026 1116073363 CMS
GlaxoSmithKline, LLC. $17.91 02/22/2024 Food and Beverage Undisputed 01/23/2026 1116620423 CMS
GlaxoSmithKline, LLC. $5.25 03/05/2024 Food and Beverage Undisputed 01/23/2026 1116517216 CMS
GlaxoSmithKline, LLC. $22.38 03/12/2024 Food and Beverage Undisputed 01/23/2026 1116385474 CMS
GlaxoSmithKline, LLC. $33.00 03/13/2024 Food and Beverage Undisputed 01/23/2026 1116511843 CMS
GlaxoSmithKline, LLC. $23.15 04/17/2024 Food and Beverage Undisputed 01/23/2026 1116206178 CMS
GlaxoSmithKline, LLC. $29.00 04/17/2024 Food and Beverage Undisputed 01/23/2026 1116260937 CMS
GlaxoSmithKline, LLC. $20.20 05/14/2024 Food and Beverage Undisputed 01/23/2026 1116564848 CMS
GlaxoSmithKline, LLC. $14.43 06/11/2024 Food and Beverage Undisputed 01/23/2026 1116240554 CMS
GlaxoSmithKline, LLC. $17.05 07/30/2024 Food and Beverage Undisputed 01/23/2026 1115971507 CMS
GlaxoSmithKline, LLC. $15.85 08/15/2024 Food and Beverage Undisputed 01/23/2026 1116715979 CMS
GlaxoSmithKline, LLC. $20.09 11/21/2024 Food and Beverage Undisputed 01/23/2026 1116483869 CMS
Grifols USA, LLC $16.09 03/06/2024 Food and Beverage Undisputed 01/23/2026 1124729449 CMS
Grifols USA, LLC $15.19 06/04/2024 Food and Beverage Undisputed 01/23/2026 1124729445 CMS
Grifols USA, LLC $15.78 09/11/2024 Food and Beverage Undisputed 01/23/2026 1124729447 CMS
kaleo, Inc. $17.71 05/08/2024 Food and Beverage Undisputed 01/23/2026 1126623700 CMS
kaleo, Inc. $24.92 07/25/2024 Food and Beverage Undisputed 01/23/2026 1126623702 CMS
Novartis Pharmaceuticals Corporation $16.93 02/14/2024 Food and Beverage Undisputed 01/23/2026 1087035706 CMS
Novartis Pharmaceuticals Corporation $15.36 07/17/2024 Food and Beverage Undisputed 01/23/2026 1087035714 CMS
Optinose US, Inc. $23.18 04/15/2024 Food and Beverage Undisputed 01/23/2026 1142192675 CMS
Optinose US, Inc. $2.59 04/16/2024 Food and Beverage Undisputed 01/23/2026 1142192665 CMS
Optinose US, Inc. $2.65 05/29/2024 Food and Beverage Undisputed 01/23/2026 1142192655 CMS
Optinose US, Inc. $20.84 05/29/2024 Food and Beverage Undisputed 01/23/2026 1142192659 CMS
Optinose US, Inc. $22.06 07/10/2024 Food and Beverage Undisputed 01/23/2026 1142192649 CMS
Optinose US, Inc. $0.55 07/11/2024 Food and Beverage Undisputed 01/23/2026 1142192641 CMS
Optinose US, Inc. $2.82 07/11/2024 Food and Beverage Undisputed 01/23/2026 1142192645 CMS
Optinose US, Inc. $0.62 08/15/2024 Food and Beverage Undisputed 01/23/2026 1142192683 CMS
Optinose US, Inc. $3.63 08/15/2024 Food and Beverage Undisputed 01/23/2026 1142192685 CMS
Optinose US, Inc. $21.95 08/15/2024 Food and Beverage Undisputed 01/23/2026 1142192687 CMS
Optinose US, Inc. $0.70 09/26/2024 Food and Beverage Undisputed 01/23/2026 1142192699 CMS
Optinose US, Inc. $3.44 09/26/2024 Food and Beverage Undisputed 01/23/2026 1142192707 CMS
Optinose US, Inc. $16.27 09/26/2024 Food and Beverage Undisputed 01/23/2026 1142192717 CMS
Optinose US, Inc. $0.63 11/26/2024 Food and Beverage Undisputed 01/23/2026 1142192697 CMS
Optinose US, Inc. $3.07 11/26/2024 Food and Beverage Undisputed 01/23/2026 1142192703 CMS
Optinose US, Inc. $20.25 11/26/2024 Food and Beverage Undisputed 01/23/2026 1142192729 CMS
Regeneron Healthcare Solutions, Inc. $57.82 06/19/2024 Education Undisputed 01/23/2026 1114095403 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.